Guideline on the clinical investigation of medicinal products for the treatment of attention deficit hyperactivity disorder (ADHD) - Committee for Medicinal Products For Human Use (CHMP) (Committee for Medicinal Products For Human Use, 2010)
(Accessed 08 October 2014)